GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Research & Development

Curocell (XKRX:372320) Research & Development : ₩ Mil (TTM As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Curocell's Research & Development for the six months ended in Jun. 2023 was ₩12,175.88 Mil. Curocell does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Jun. 2023.


Curocell Research & Development Historical Data

The historical data trend for Curocell's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Research & Development Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
3,933.87 8,931.15 13,156.62 19,670.19 27,190.71

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Research & Development 9,723.88 9,946.32 12,175.88 15,014.84

Curocell Research & Development Calculation

This is the expense the company spent on research and development.


Curocell  (XKRX:372320) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Curocell Research & Development Related Terms

Thank you for viewing the detailed overview of Curocell's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines